SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001140361-22-026304
Filing Date
2022-07-19
Accepted
2022-07-19 07:13:11
Documents
3
Group Members
RHUMBA MERGER SUB INC

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A brhc10039766_sctota.htm SC TO-T/A 31335
2 EXHIBIT 99 (A)(5)(VIII) brhc10039766_ex99-a5viii.htm EX-99.(A)(5)(VIII) 14096
3 image0.jpg GRAPHIC 29721
  Complete submission text file 0001140361-22-026304.txt   88371
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filed by) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Subject) CIK: 0001595893 (see all company filings)

IRS No.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-90986 | Film No.: 221090327
SIC: 2834 Pharmaceutical Preparations